当前位置:首页 - 行情中心 - 锦波生物(920982) - 财务分析 - 现金流量表

锦波生物

(920982)

  

流通市值:131.66亿  总市值:275.93亿
流通股本:5490.51万   总股本:1.15亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,336,271,300.35882,163,806.93421,457,793.251,449,793,114.41
  收到的税费返还---29.9
  收到其他与经营活动有关的现金44,272,434.7226,068,727.368,267,486.4929,058,060.33
  经营活动现金流入小计1,380,543,735.07908,232,534.29429,725,279.741,478,851,204.64
  购买商品、接受劳务支付的现金125,168,020.0186,109,816.2642,728,352.53110,602,361.94
  支付给职工以及为职工支付的现金206,071,312.61140,982,333.2579,510,784.48206,436,437.79
  支付的各项税费231,084,952.12130,992,069.6854,200,704.79158,742,701.54
  支付其他与经营活动有关的现金263,996,231.13167,442,865.3479,061,986.75235,914,309
  经营活动现金流出小计826,320,515.87525,527,084.53255,501,828.55711,695,810.27
  经营活动产生的现金流量净额554,223,219.2382,705,449.76174,223,451.19767,155,394.37
二、投资活动产生的现金流量:
  收回投资收到的现金1,650,000,0001,050,000,000440,000,000750,000,000
  取得投资收益收到的现金4,889,164.882,885,501.071,024,969.321,277,383.57
  投资活动现金流入小计1,654,889,164.881,052,885,501.07441,024,969.32751,277,383.57
  购建固定资产、无形资产和其他长期资产支付的现金279,959,008.52223,492,946.32149,635,084.44155,602,493.76
  投资支付的现金1,680,000,0001,050,000,000440,000,000750,000,000
  投资活动现金流出小计1,959,959,008.521,273,492,946.32589,635,084.44905,602,493.76
  投资活动产生的现金流量净额-305,069,843.64-220,607,445.25-148,610,115.12-154,325,110.19
三、筹资活动产生的现金流量:
  吸收投资收到的现金5,900,0001,000,0001,000,000-
  其中:子公司吸收少数股东投资收到的现金5,900,0001,000,0001,000,000-
  取得借款收到的现金---70,000,000
  收到其他与筹资活动有关的现金3,500,0003,500,0001,750,0004,558,159.77
  筹资活动现金流入小计9,400,0004,500,0002,750,00074,558,159.77
  偿还债务支付的现金21,310,17114,510,1718,500,00099,308,837.88
  分配股利、利润或偿付利息支付的现金294,019,083.36178,371,660.86687,870.99161,097,185.17
  支付其他与筹资活动有关的现金4,574,478.92,545,223.741,618,689.44,424,247.02
  筹资活动现金流出小计319,903,733.26195,427,055.610,806,560.39264,830,270.07
  筹资活动产生的现金流量净额-310,503,733.26-190,927,055.6-8,056,560.39-190,272,110.3
四、汇率变动对现金及现金等价物的影响-56,021.17-15,387.4-3,035.8519,004.78
五、现金及现金等价物净增加额-61,406,378.87-28,844,438.4917,553,739.83422,577,178.66
  加:期初现金及现金等价物余额941,124,763.4941,124,763.4941,124,763.4518,547,584.74
  期末现金及现金等价物余额879,718,384.53912,280,324.91958,678,503.23941,124,763.4
补充资料:
  净利润-390,711,169.36-731,174,533.67
  资产减值准备-10,822,324.14-13,872,526.14
  固定资产和投资性房地产折旧-26,499,849.13-44,045,168.94
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-26,499,849.13-44,045,168.94
  无形资产摊销-5,538,288.21-4,854,083.91
  长期待摊费用摊销-2,022,549.32-4,322,014.16
  固定资产报废损失-1,597,779.02-45,675.32
  财务费用-4,013,704.39-10,469,527.89
  投资损失--2,885,501.07--1,277,383.57
  递延所得税--2,323,172.27--2,003,526.5
  其中:递延所得税资产减少--2,178,350.71--1,713,883.38
    递延所得税负债增加--144,821.56--289,643.12
  存货的减少--58,252,088.1--36,348,175.39
  经营性应收项目的减少--85,381,813.26--90,650,859.68
  经营性应付项目的增加-70,607,697.84-79,833,134.92
  其他-9,196,955.8--8,320,511.54
  不涉及现金收支的投资和筹资活动金额其他项目---12,203,455.01
  现金的期末余额-912,280,324.91-941,124,763.4
  减:现金的期初余额-941,124,763.4-518,547,584.74
  现金及现金等价物的净增加额--28,844,438.49-422,577,178.66
公告日期2025-10-292025-08-112025-04-222025-04-21
审计意见(境内)标准无保留意见
TOP↑